Selling Buzz: Resmed Inc. [RMD] Global General Counsel Rider Michael J sells 81 shares of the company

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Resmed Inc. shares valued at $14,580 were sold by Rider Michael J on Mar 04 ’24. At $180.00 per share, Rider Michael J sold 81 shares. The insider’s holdings dropped to 6,607 shares worth approximately $1.3 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Rider Michael J sold 200 shares, netting a total of over 34,650 in proceeds. Following the sale of shares at $173.25 each, the insider now holds 6,688 shares.

Before that, FARRELL PETER C had sold 10,935 shares from its account. In a trade valued at $1,997,434, the Director traded Resmed Inc. shares for $182.66 each. Upon closing the transaction, the insider’s holdings decreased to 10,935 shares, worth approximately $30.9 million.

Analysts at Morgan Stanley upgraded the stock from ‘”an Equal-weight”‘ to ‘”an Overweight”‘ outlook in a report released in late October. As of October 12, 2023, RBC Capital Mkts has decreased its “an Outperform” rating to a “Sector perform” for RMD. Earlier on October 09, 2023, JP Morgan upgraded its rating. Their new recommendation was “an Overweight” for RMD stock which previously was a “a Neutral”.

Analyzing RMD Stock Performance

During the last five days, there has been a surge of approximately 2.05%. Over the course of the year, Resmed Inc. shares have jumped approximately 14.13%. Shares of the company reached a 52-week high of $197.85 on 01/29/24 and a 52-week low of $164.12 on 01/04/24. A 50-day SMA is recorded $185.15, while a 200-day SMA reached $175.39. Nevertheless, trading volume fell to 0.57 million shares from 1.84 million shares the previous day.

Support And Resistance Levels for Resmed Inc. (RMD)

According to the 24-hour chart, there is a support level at 194.78, which, if violated, would cause prices to drop to 193.22. In the upper region, resistance lies at 197.32. The next price resistance is at 198.30. RSI (Relative Strength Index) is 63.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.31, which suggests the price will increase in the coming days. Percent R is at 3.40%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is Resmed Inc. subject to short interest?

Stocks of Resmed Inc. saw a sharp rise in short interest on Mar 15, 2024 jumping by 1.08 million shares to 7.66 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 6.58 million shares. A jump of 14.1% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.58 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.58.

Most Popular